Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat

European Urology

Volumn 58, Issue 4, 2010, Pages 616-625

  Caremel, Romain ^a   Oger Roussel, Stephanie ^b   Behr Roussel, Delphine ^b   Grise, Philippe ^a   Giuliano, François A ^c,d  

^a HÔPITAL CHARLES NICOLLE   (France)

^b Pelvipharm   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Afferent fibers; Cystometry; Nitric oxide cGMP pathway; Overactive bladder; Pharmacology

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; CAPSAICIN; CYCLIC GMP; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE; SILDENAFIL; VARDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER INSTABILITY; BLADDER PRESSURE; CYSTOMETRY; FEMALE; MICTURITION REFLEX; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SOMATOSENSORY SYSTEM; URINE VOLUME;

ANIMALS; CYCLIC GMP; FEMALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REFLEX; SENSATION; SIGNAL TRANSDUCTION; URINATION;

EID: 78650681639     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.07.026     Document Type: Article

References (29)

1. W.C. de Groat, and N. Yoshimura Afferent nerve regulation of bladder function in health and disease Handb Exp Pharmacol 2009 91 138
2. L.A. Birder Urinary bladder urothelium: molecular sensors of chemical/thermal/mechanical stimuli Vascul Pharmacol 45 2006 221 226
3. P.J. Smet, K.H. Moore, and J. Jonavicius Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder Lab Invest 77 1997 37 49
4. B. Fathian-Sabet, W. Bloch, and T. Klotz Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder J Urol 165 2001 1724 1729
5. H. Tinel, B. Stelte-Ludwig, J. Hutter, and P. Sandner Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms BJU Int 98 2006 1259 1263
6. B. Fibbi, A. Morelli, and L. Vignozzi Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract J Sex Med 7 2010 59 69
7. H. Ozawa, M.B. Chancellor, and S.Y. Jung Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis J Urol 162 1999 2211 2216
8. R.K. Pandita, H. Mizusawa, and K.E. Andersson Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats J Urol 164 2000 545 550
9. H. Masuda, J.H. Kim, K. Kihara, M.B. Chancellor, W.C. de Groat, and N. Yoshimura Inhibitory roles of peripheral nitrergic mechanisms in capsaicin-induced detrusor overactivity in the rat BJU Int 100 2007 912 918
10. K. Persson, Y. Igawa, A. Mattiasson, and K.E. Andersson Effects of inhibition of the L-arginine/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro Br J Pharmacol 107 1992 178 184
11. K. Sasatomi, S. Hiragata, M. Miyazato, M.B. Chancellor, S.M. Morris Jr., and N. Yoshimura Nitric oxide-mediated suppression of detrusor overactivity by arginase inhibitor in rats with chronic spinal cord injury Urology 72 2008 696 700
12. S. Filippi, A. Morelli, and P. Sandner Characterization and functional role of androgen-dependent PDE5 activity in the bladder Endocrinology 148 2007 1019 1029
13. K.T. McVary, W. Monnig, J.L. Camps Jr., J.M. Young, L.J. Tseng, and E.G. van Den Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial J Urol 177 2007 1071 1077
14. K.T. McVary, C.G. Roehrborn, and J.C. Kaminetsky Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 177 2007 1401 1407
15. C.G. Stief, H. Porst, D. Neuser, M. Beneke, and E. Ulbrich A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia Eur Urol 53 2008 1236 1244
16. C.G. Roehrborn, K.T. McVary, A. Elion-Mboussa, and L. Viktrup Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study J Urol 180 2008 1228 1234
17. Tamimi NA, Mincik I, Haughie S, Lamb J, Crossland A, Ellis P. A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia. BJU Int. In press. DOI:10.1111/j.1464-410X.2010.09204.x.
18. M. Gacci, G. Del Popolo, and A. Macchiarella Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study J Urol 178 2007 2040 2043
19. P. Alm, P.K. Zygmunt, and C. Iselin Nitric oxide synthase-immunoreactive, adrenergic, cholinergic, and peptidergic nerves of the female rat urinary tract: a comparative study J Auton Nerv Syst 56 1995 105 114
20. A. Moon Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro BJU Int 89 2002 942 949
21. S. Oger, D. Behr-Roussel, and D. Gorny Signaling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle Br J Pharmacol 160 2010 1135 1143
22. B.C. Bennett, M.N. Kruse, J.R. Roppolo, H.D. Flood, M. Fraser, and W.C. de Groat Neural control of urethral outlet activity in vivo: role of nitric oxide J Urol 153 1995 2004 2009
23. H. Nagabukuro, A. Degenhardt, and K.L. Villa Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats Auton Neurosci 156 2010 19 26
24. D. Behr-Roussel, S. Oger, S. Caisey, P. Sandner, J. Bernabe, and F. Giuliano Vardenafil decreases bladder afferent nerve activity in unanesthetized decerebrate spinal cord-injured rats Eur Urol Supp 9 2010 73
25. M. Saito, and I. Miyagawa Direct detection of nitric oxide in rat urinary bladder during ischemia-reperfusion J Urol 162 1999 1490 1495
26. D.C. Kelly, A.U. Asghar, C.G. Marr, and D.S. McQueen Nitric oxide modulates articular sensory discharge and responsiveness to bradykinin in normal and arthritic rats in vivo Neuroreport 12 2001 121 125
27. G.D. Chen, M.L. Peng, and P.Y. Wang Calcium/calmodulin-dependent kinase II mediates NO-elicited PKG activation to participate in spinal reflex potentiation in anesthetized rats Am J Physiol Regul Integr Comp Physiol 294 2008 R487 R493
28. A.J. Page, T.A. O'Donnell, N.J. Cooper, R.L. Young, and L.A. Blackshaw Nitric oxide as an endogenous peripheral modulator of visceral sensory neuronal function J Neurosci 29 2009 7246 7255
29. C.S. Patil, V.P. Singh, S. Singh, and S.K. Kulkarni Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy Pharmacology 72 2004 190 195